Exclude Patient Type Detail Header
No
Footnote
<sup>1</sup> Moeller KE, et al. Clinical Interpretation of Urine Drug Tests: What Clinicians Need to Know About Urine Drug Screens. <i>Mayo Clin Proc.</i> 2017 May;92(5):774-796. <a href=https://www.mayoclinicproceedings.org/action/showPdf?pii=S0025-6196%2816%2930825-4><u>Free, full-text PDF</u></a>
Detail Type
Text
Patient Type Detail Header (Long)
BZD immunoassays are limited by high cutoff values and/or inability to detect conjugated metabolites; most immunoassays detect free or nonconjugated oxazepam or nordiazepam forms (common metabolites of several BZDs).